Your browser doesn't support javascript.
loading
Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkish oncology group study.
Acar, Ramazan; Paydas, Semra; Yildirim, Murat; Kiliçarslan, Emrah; Sahin, Ugur; Dogan, Ali; Guven, Deniz C; Ekinci, Omer; Tiglioglu, Mesut; Erdogan, Isil; Elibol, Tayfun; Kiziloz, Halil; Aykan, Musa B; Sayin, Selim; Kaptan, Kursat; Soydan, Ender; Gokmen, Ayla; Esen, Ramazan; Barista, Ibrahim; Albayrak, Murat; Erturk, Ismail; Yildiz, Birol; Keskin, Gulsema Y; Ayli, Meltem; Karadurmus, Nuri.
Afiliación
  • Acar R; Department of Medical Oncology, Mersin City, Research and Training Hospital, University of Health Science, Mersin, Turkey.
  • Paydas S; Department of Medical Oncology, School of Medicine, University of Cukurova, Adana, Turkey.
  • Yildirim M; Department of Hematology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey.
  • Kiliçarslan E; Department of Medical Hematology, Sultan Abdulhamid Han Research and Training Hospital, University of Health Science, Istanbul, Turkey.
  • Sahin U; Department of Hematology, Medicana International Hospital, Ankara, Turkey.
  • Dogan A; Department of Hematology, Van Yuzuncu Yil School of Medicine, University of Van Yuzuncu Yil, Van, Turkey.
  • Guven DC; Department of Medical Oncology, Hacettepe School of Medicine, University of Hacettepe, Ankara, Turkey.
  • Ekinci O; Department of Hematology, Firat School of Medicine, University of Firat, Elazig, Turkey.
  • Tiglioglu M; Department of Hematology, Diskapi Research and Training Hospital, University of Health Science, Ankara, Turkey.
  • Erdogan I; Department of Hematology, Goztepe Research and Training Hospital, University of Istanbul Medeniyet, Ankara, Turkey.
  • Elibol T; Department of Hematology, Goztepe Research and Training Hospital, University of Istanbul Medeniyet, Ankara, Turkey.
  • Kiziloz H; Department of Urology, Nevsehir Government Hospital, Nevsehir, Turkey.
  • Aykan MB; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey.
  • Sayin S; Department of Medical Oncology, School of Medicine, University of Cukurova, Adana, Turkey.
  • Kaptan K; Department of Medical Hematology, Sultan Abdulhamid Han Research and Training Hospital, University of Health Science, Istanbul, Turkey.
  • Soydan E; Department of Hematology, Medicana International Hospital, Ankara, Turkey.
  • Gokmen A; Department of Hematology, Medicana International Hospital, Ankara, Turkey.
  • Esen R; Department of Hematology, Van Yuzuncu Yil School of Medicine, University of Van Yuzuncu Yil, Van, Turkey.
  • Barista I; Department of Medical Oncology, Hacettepe School of Medicine, University of Hacettepe, Ankara, Turkey.
  • Albayrak M; Department of Hematology, Diskapi Research and Training Hospital, University of Health Science, Ankara, Turkey.
  • Erturk I; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey.
  • Yildiz B; Department of Medical Oncology, Medical Park Hospital, Ankara, Turkey.
  • Keskin GY; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey.
  • Ayli M; Department of Hematology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey.
  • Karadurmus N; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey.
J Cancer Res Ther ; 19(Supplement): S138-S144, 2023 Apr.
Article en En | MEDLINE | ID: mdl-37147993

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Turquía